| Cutaneous LMS (n = 42) | Subcutaneous LMS (n = 166) | p-value |
---|---|---|---|
Age | 63 [31-89] | 62 [1- 88] | 0.976 |
Size (cm) | 4.00 [0.50-12.40] | 5.00 [0.50-50.00] | 0.002 |
Definitive surgery | Â | Â | Â |
 Simple tumorectomy | 32 (82.1%) | 19 (11.9%) | <0.001 |
 With orchiectomy | 7 (17.9%) | 140 (88.1%) |  |
Surgical margin | Â | Â | Â |
 Negative | 20 (100.0%) | 36 (81.8%) | 0.049 |
 Positive | 0 (0.0%) | 8 (18.2%) |  |
Tumor grade | Â | Â | Â |
 Grade 1 | 13 (41.9%) | 40 (27.2%) | 0.101 |
 Grade 2 | 11 (35.5%) | 50 (34.0%) |  |
 Grade 3 | 7 (22.6%) | 57 (38.8%) |  |
Adjuvant radiation therapy | Â | Â | Â |
 No | 34 (89.5%) | 121 (81.8%) | 0.333 |
 Yes | 4 (10.5%) | 27 (18.2%) |  |
Adjuvant chemotherapy | Â | Â | Â |
 No | 36 (94.7%) | 137 (92.6%) | 1.000 |
 Yes | 2 (5.3%) | 11 (7.4%) |  |